Cleared Abbreviated

SRX Handheld Doppler, DMX Handheld Doppler, Obstetric Probes, Vascular Probes (K183574) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through the Abbreviated 510(k) pathway - typically does not require clinical trials.

K183574 · Huntleigh Healthcare , Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2019
Decision
259d
Days
Class 2
Risk

K183574 is an FDA 510(k) clearance for the SRX Handheld Doppler, DMX Handheld Doppler, Obstetric Probes, Vascular Probes. Classified as Flowmeter, Blood, Cardiovascular (product code DPW), Class II - Special Controls.

Submitted by Huntleigh Healthcare , Ltd. (Cardiff, GB). The FDA issued a Cleared decision on September 6, 2019 after a review of 259 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2100 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Huntleigh Healthcare , Ltd. devices

Submission Details

510(k) Number K183574 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 21, 2018
Decision Date September 06, 2019
Days to Decision 259 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
134d slower than avg
Panel avg: 125d · This submission: 259d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code DPW Flowmeter, Blood, Cardiovascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPW Flowmeter, Blood, Cardiovascular

All 25
Devices cleared under the same product code (DPW) and FDA review panel - the closest regulatory comparables to K183574.
Bidop 7
K201114 · Koven Technology, Inc. · Jan 2021
FloPatch (FP120)
K200337 · Flosonics Medical (R/A 1929803 Ontario Corp.) · Mar 2020
FlowMet
K192966 · Laser Associated Sciences, Inc. · Jan 2020
FloPatch (FP110)
K191388 · Flosonics Medical (R/A 1929803 Ontario Corp.) · Jun 2019
FlowMet-R
K182494 · Laser Associated Sciences, Inc. · Feb 2019
iCertainty
K181269 · Rfpi · Dec 2018